A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Sep, 24 2025
Nov, 9 2023
Feb, 11 2026
Oct, 8 2025
Oct, 13 2025